• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Medical Tubing and Extrusion

Medical tubing and extrusion technologies

  • Technologies
    • Balloons
    • Brain-computer interfaces
    • Cardiac Implants
    • Catheters
    • Endoscopes
    • Heart valves
    • Pulsed Field Ablation
  • Components
    • Connectors
    • Needles and Injections
    • Seals
    • Tubing Components
  • Manufacturing
    • Coatings
    • Extrusions
    • Machining
    • Molding
      • Injection Molding
      • Insert molding
      • Mold Components
    • Tools
  • Materials
    • Advanced Materials
    • Metals
    • Nitinol
    • Plastics
    • Silicone
  • Business
    • Distribution Agreements
    • Legal News
    • Mergers & Acquisitions
    • Partnerships
    • Personnel Moves
  • Regulatory
    • 510(k)
    • CE Mark
    • FDA Breakthrough Designation
    • ISO Certification
    • Pre-Market Approval (PMA)
    • Recalls
  • Suppliers
  • About Us

Medtronic enrolls first patient in aneurysm repair trial

February 1, 2024 By Sean Whooley

Medtronic-AAA-repair copy
The Endurant II/IIs stent graft systems (left) and Heli-FX EndoAnchor system (right) [Images courtesy of Medtronic]
Medtronic [WtwhTicker symbol=”MDT”](NYSE: MDT)[/WtwhTicker] announced today that it enrolled the first patient in the Hercules trial comparing abdominal aortic aneurysm repair methods.

Hercules compares endosuture aneurysm repair (ESAR) to standard endovascular aneurysm repair (EVAR). It looks at these methods in patients who have an abdominal aortic aneurysm (AAA) with a wide, infrarenal neck diameter.

Abdominal aortic aneurysms occur in about 1.4% of people ages 50 to 84 in the U.S., according to Cleveland Clinic. Aging, tobacco use and certain medical conditions can cause the aorta’s wall to weaken and bulge. A burst is life-threatening. Over more than a decade, Medtronic’s Endurant stents have grown as an alternative to open surgery.

Patients in the Hercules trial will receive either the Endurant II/IIs stent graft (EVAR arm) or the Endurant II/IIs stent graft in conjunction with the Heli-FX EndoAnchor system (ESAR arm). The Heli-FX EndoAnchor provides transmural fixation of the endograft to the aorta in order to help reduce later complications.

Medtronic plans to recruit a total of 300 patients worldwide. It expects the trial to take place at approximately 20 hospitals in Europe and 20 in the U.S.

According to a news release from Rijnstate Hospital, both the condition and surgery carry risks. Many aneurysms require minimally invasive treatment featuring a stent graft inserted into the abdominal artery. The area where the stent graft attaches under the renal artery is referred to as the “neck.”

Dr. Michel Riejnen, the principal investigator for the Hercules trial, says about a quarter of all patients with an aneurysm have a wide neck. This means the top of the aneurysm registers wider than normal. That can increase the risk of longer-term complications after surgery through the groin.

Risks can include the displacement of the stent and leakage in the aneurysm. That increases the risk of rupture again, often leading to another surgery.

“By securing the stent graft to the vessel wall in the neck with specially developed implants, called EndoAnchors, we try to prevent complications and associated re-operations. Next, we must investigate whether this is really the case,” the doctor said. “We will do that in the coming years.”

Filed Under: Stents Tagged With: medtronic

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“mte
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest trends and developments in medical tubing and extrusion.
MDO ad

Sponsored Content

A new way to access scientific papers?

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Inv Logo

MASSDEVICE MEDICAL NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World
Drug Delivery Business News

Medical Tubing + Extrusion

Subscribe to our E-Newsletter
Advertise with us
About
Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS